XCUR vs AUID Comparison

Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.

AuthID Inc is a company engaged in ensuring enterprises - Know Who's Behind the Device, for every customer or employee login and transaction, through its easy-to-integrate, patented, biometric identity platform. authID powers biometric identity proofing, biometric authentication, and account recovery with a fast, accurate, user-friendly experience. With its PrivacyKey solution, authID provides accurate biometric authentication while storing no biometric data. authID's goal is to stop fraud at onboarding, blocks deepfakes, prevents account takeover, and eliminates password risks and costs, through the faster, and accurate user identity experience demanded by the digital ecosystem Its products are: IDX Mandate for Agentic AI, PrivacyKey, Identity Verification, and Biometric Authentication.